Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

Published:2023-09-20 Issue: Volume:10 Page:44-53
ISSN:2331-4737
Container-title:Oncoscience
language:en
Short-container-title:Oncoscience

Author:

Gouda Mohamed A.¹,Zarzour Maria A.²,Vaporciyan Ara A.³,Kairemo Kalevi⁴,Chuang Hubert H.⁴,Subbiah Vivek¹⁵

Affiliation:

1. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

3. Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

4. Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

5. Sarah Cannon Research Institute, Nashville, TN 37203, USA

Publisher

Impact Journals, LLC

Subject

Cancer Research,Oncology

Reference69 articles.

1. Subbiah V, Kurzrock R. Phase 1 clinical trials for sarcomas: the cutting edge. Curr Opin Oncol. 2011; 23:352–60. https://doi.org/10.1097/CCO.0b013e3283477a94. PMID:21519259

2. Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing’s sarcoma: standard and experimental treatment options. Curr Treat Options Oncol. 2009; 10:126–40. https://doi.org/10.1007/s11864-009-0104-6. PMID:19533369

3. Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, et al. Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clin Cancer Res. 2019; 25:3802–10. https://doi.org/10.1158/1078-0432.CCR-18-3964. PMID:30733229

4. Subbiah V, Kurzrock R. Ewing’s sarcoma: overcoming the therapeutic plateau. Discov Med. 2012; 13:405–15. PMID:22742646

5. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012; 87:475–87. https://doi.org/10.1016/j.mayocp.2012.01.015. PMID:22560526

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3